Biote Corp Stock Today
| BTMD Stock | USD 3.76 0.69 22.48% |
PerformanceVery Weak
| Odds Of DistressVery Low
|
Biote Corp is trading at 3.76 as of the 17th of March 2025, a 22.48% increase since the beginning of the trading day. The stock's lowest day price was 3.1. Biote Corp has under 5 % chance of experiencing financial distress over the next 2 years, but has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 17th of December 2024 and ending today, the 17th of March 2025. Click here to learn more.
Business Domain Health Care Equipment & Services | IPO Date 28th of April 2021 | Category Healthcare | Classification Health Care |
biote Corp. operates in medical practice-building business within the hormone optimization space. The company was founded in 2011 and is headquartered in Irvine, Texas. Biote Corp operates under Medical Care Facilities classification in the United States and is traded on NASDAQ Exchange.. The company has 31.11 M outstanding shares of which 682.03 K shares are currently shorted by private and institutional investors with about 3.97 trading days to cover. More on biote Corp
Moving together with Biote Stock
Moving against Biote Stock
Biote Stock Highlights
ESG Sustainability
Environmental | Governance | Social |
| CEO Director | Bret Christensen | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Health Care Equipment & Supplies, Health Care Equipment & Services, Health Care, NASDAQ Composite, NASDAQ Health Care, Health Care, Health Care Equipment & Supplies, Medical Care Facilities, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt LevelsBiote Corp can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Biote Corp's financial leverage. It provides some insight into what part of Biote Corp's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
biote Corp (BTMD) is traded on NASDAQ Exchange in USA. It is located in 1875 W. Walnut Hill Ln #100, Irving, TX, United States, 75038 and employs 17 people. Biote Corp is listed under Health Care Equipment & Supplies category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with a current market capitalization of 198.34 M. biote Corp conducts business under Health Care Equipment & Supplies sector and is part of Health Care industry. The entity has 31.11 M outstanding shares of which 682.03 K shares are currently shorted by private and institutional investors with about 3.97 trading days to cover.
biote Corp currently holds about 82.72 M in cash with 45.24 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.22.
Check Biote Corp Probability Of Bankruptcy
Ownership AllocationBiote Corp holds a total of 31.11 Million outstanding shares. Over half of Biote Corp's outstanding shares are owned by other corporate entities. These other corporate entities are typically referred to as corporate investors that acquire positions in a given instrument to benefit from reduced trade commissions. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Biote Ownership Details
Biote Stock Institutional Holders
| Instituion | Recorded On | Shares | |
| Northern Trust Corp | 2024-12-31 | 288.3 K | |
| Globeflex Capital, L.p. | 2024-12-31 | 272.4 K | |
| Jacobs Levy Equity Management, Inc. | 2024-12-31 | 270.5 K | |
| Hillsdale Investment Management Inc. | 2024-12-31 | 252.5 K | |
| Renaissance Technologies Corp | 2024-12-31 | 179 K | |
| Goldman Sachs Group Inc | 2024-12-31 | 178.8 K | |
| Skylands Capital, Llc | 2024-12-31 | 159.5 K | |
| Bank Of New York Mellon Corp | 2024-12-31 | 105.9 K | |
| Ubs Group Ag | 2024-12-31 | 103.8 K | |
| 325 Capital Llc | 2024-12-31 | 4.5 M | |
| Bandera Partners Llc | 2024-12-31 | 2.4 M |
Biote Corp Historical Income Statement
Biote Stock Against Markets
Biote Corp Corporate Management
| Teresa Weber | CEO Director | Profile | |
| Samar Kamdar | Principal CFO | Profile | |
| Ross MD | Chief Officer | Profile | |
| Jennifer Schimmel | Director Talent | Profile | |
| James II | Chief Officer | Profile | |
| Robert Peterson | Chief Officer | Profile |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in biote Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. For information on how to trade Biote Stock refer to our How to Trade Biote Stock guide.You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Biote Corp. If investors know Biote will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Biote Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of biote Corp is measured differently than its book value, which is the value of Biote that is recorded on the company's balance sheet. Investors also form their own opinion of Biote Corp's value that differs from its market value or its book value, called intrinsic value, which is Biote Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Biote Corp's market value can be influenced by many factors that don't directly affect Biote Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Biote Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Biote Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biote Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.